Sharps Technology (NASDAQ:STSS) versus SANUWAVE Health (OTCMKTS:SNWV) Critical Analysis

Risk and Volatility

SANUWAVE Health has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 2.08, meaning that its stock price is 108% more volatile than the S&P 500.

Earnings & Valuation

This table compares SANUWAVE Health and Sharps Technology”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SANUWAVE Health	$32.63 million	8.09	-$25.81 million	($3.90)	-7.92
Sharps Technology	N/A	N/A	-$9.84 million	($2,253.55)	0.00

Sharps Technology has lower revenue, but higher earnings than SANUWAVE Health. SANUWAVE Health is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

42.5% of SANUWAVE Health shares are held by institutional investors. Comparatively, 17.2% of Sharps Technology shares are held by institutional investors. 36.6% of SANUWAVE Health shares are held by company insiders. Comparatively, 1.5% of Sharps Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares SANUWAVE Health and Sharps Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SANUWAVE Health	-1.33%	-23.83%	-20.60%
Sharps Technology	N/A	-110.40%	-73.60%

Summary

SANUWAVE Health beats Sharps Technology on 7 of the 10 factors compared between the two stocks.

About SANUWAVE Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

About Sharps Technology

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.